Skip to content

Evaluating a Treatment Effect in Patients With FBSS Using an Electronic Nose: a Pilot Study

Evaluating a Treatment Effect in Patients With FBSS Using an Electronic Nose: a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04469738
Acronym
NOSE
Enrollment
27
Registered
2020-07-14
Start date
2020-12-12
Completion date
2021-03-27
Last updated
2021-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failed Back Surgery Syndrome

Brief summary

This study is an experimental single-center pilot study investigating Volatile Organic Compounds patterns in exhaled breath during on and off states of SCS, in patient with Failed Back Surgery Syndrome.

Interventions

Spinal cord stimulator is switched off for 12 hours

Spinal cord stimulator is functioning

Sponsors

the eNose company
CollaboratorUNKNOWN
Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of FBSS (Failed conservative treatments for pain including but not limited to pharmacological therapy and physical therapy) and currently being treated with spinal cord stimulation.

Exclusion criteria

* Patients with a diagnosis of cancer. * Patients with major psychiatric problems. * Patients with an underlying respiratory disease.

Design outcomes

Primary

MeasureTime frameDescription
Exhaled breath changesTwo times on the same day; once while SCS is switched off and once while SCS is switched on. Total study duration lasts one day.The investigators will examine the difference in exhaled breath patterns between both measurements (SCS on versus SCS off), measured with the Aeonose.

Secondary

MeasureTime frameDescription
Pain intensity scores using the Visual Analogue ScaleTwo times on the same day; once while SCS is switched off and once while SCS is switched on. Total study duration lasts one day.Pain intensity score on that time on a Visual Analogue Scale (VAS) ranging from zero (no pain) towards 10 (worst possible pain) for the pain intensity.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026